Page 1

Table of Contents ( Mark one ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ANNUAL REPORT UNDER SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 TRANSITION REPORT UNDER SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ANI PHARMACEUTICALS , INC . ( Exact name of registrant as specified in its charter ) Delaware ( State or other jurisdiction of incorporation or organization ) 210 Main Street West Baudette , Minnesota ( Address of principal executive offices ) to Commission file number 001-31812 Title of each class Common Stock , par value $ 0.0001 per share ( 218 ) 634-3500 ( Registrant's telephone number , including area code ) Securities registered pursuant to Section 12 ( b ) of the Act : Trading Symbol ANIP Securities registered pursuant to Section 12 ( g ) of the Act : None 58-2301143 ( I.R.S. Employer Identification No. ) 56623 ( Zip Code ) Name of each exchange on which registered The Nasdaq Global Market Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No X Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes No Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes > No Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company . See definitions of " large accelerated filer , ” “ accelerated filer , " " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . ( Check one ) : Large accelerated filer Non - accelerated filer Accelerated filer > Smaller reporting company Emerging growth company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . □ Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Act ) . Yes No The aggregate market value of the voting and non - voting common stock held by non - affiliates of the registrant as of June 30 , 2020 was $ 316.1 million ( based upon the last reported sale price of $ 32.34 per share on June 30 , 2020 , on The Nasdaq Global Market ) . As of March 4 , 2021 , 12,354,398 shares of common stock and 10,864 shares of Class C Special stock of the registrant were outstanding . DOCUMENTS INCORPORATED BY REFERENCE Portions of the definitive proxy statement for the registrant's 2021 annual meeting of stockholders to be filed within 120 days after the end of the period covered by this Annual Report on Form 10 - K are incorporated by reference into Part III of this Annual Report on Form 10 - K .